LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.001
42.81 27.76 2984 3596 0.8297 0.9475
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
42.81 27.76 3018 3596 0.8392 0.9507
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
42.81 27.76 1165 3596 0.3240 0.7032
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
42.81 27.76 3542 3596 0.9849 0.9957
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
44.52 27.76 3195 3884 0.8226 0.9459
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
44.52 27.76 3219 3884 0.8287 0.9480
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
44.52 27.76 1335 3884 0.3437 0.7217
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
44.52 27.76 3733 3884 0.9611 0.9889
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
46.22 27.76 3403 4125 0.8250 0.9474
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
46.22 27.76 3431 4125 0.8318 0.9496
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
46.22 27.76 1416 4125 0.3433 0.7245
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
46.22 27.76 3925 4125 0.9515 0.9863
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
47.93 27.76 3603 4421 0.8149 0.9448
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
47.93 27.76 3631 4421 0.8212 0.9469
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
47.93 27.76 1647 4421 0.3725 0.7475
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
47.93 27.76 4174 4421 0.9440 0.9843
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
49.63 27.76 3820 4818 0.7929 0.9386
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
49.63 27.76 3845 4818 0.7980 0.9403
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
49.63 27.76 1862 4818 0.3865 0.7601
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
49.63 27.76 4355 4818 0.9039 0.9730
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
51.33 27.76 4021 5117 0.7858 0.9370
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
51.33 27.76 4043 5117 0.7901 0.9384
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
51.33 27.76 1950 5117 0.3811 0.7594
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
51.33 27.76 4649 5117 0.9085 0.9747
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
53.04 27.76 4240 5365 0.7902 0.9389
MN20160318_Q01
H11